Cannabinoids for the Treatment of Dermatologic Conditions
In recent years, cannabinoid (CB) products have gained popularity among the public. The anti-inflammatory properties of CBs have piqued the interest of researchers and clinicians because they represent promising avenues for the treatment of autoimmune and inflammatory skin disorders that may be refr...
Main Authors: | Torunn E. Sivesind, Jalal Maghfour, Hope Rietcheck, Kevin Kamel, Ali S. Malik, Robert P. Dellavalle |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | JID Innovations |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026722000017 |
Similar Items
-
Gamification and Game-Based Strategies for Dermatology Education: Narrative Review
by: Mindy D Szeto, et al.
Published: (2021-08-01) -
Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication
by: Torunn E Sivesind, et al.
Published: (2022-06-01) -
Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review
by: Jalal Maghfour, et al.
Published: (2021-10-01) -
From the Cochrane Library: Interventions for Hidradenitis Suppurativa
by: Jalal Maghfour, et al.
Published: (2022-03-01) -
Mortality Outcomes in Dermatology: An Exploration of Core Outcome Sets and Cochrane Skin Systematic Reviews
by: Torunn E Sivesind, et al.
Published: (2022-02-01)